Hematopoietic stem cell transplantation for CD40 ligand deficiency: Results from an EBMT/ESID-IEWP-SCETIDE-PIDTC study
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, cilt.143, sa.6, ss.2238-2253, 2019 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 143 Sayı: 6
- Basım Tarihi: 2019
- Doi Numarası: 10.1016/j.jaci.2018.12.1010
- Dergi Adı: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.2238-2253
- Anahtar Kelimeler: CD40 ligand, hematopoietic stem cell transplantation, X-linked hyper-IgM syndrome, primary immunodeficiency, BONE-MARROW-TRANSPLANTATION, HYPER-IGM SYNDROME, X-LINKED IMMUNODEFICIENCY, IMMUNOGLOBULIN-M SYNDROME, DEFECTIVE EXPRESSION, CLINICAL-FEATURES, T-CELLS, CHILDREN, EXPERIENCE, MUTATIONS
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- Ankara Üniversitesi Adresli: Evet
Özet
Background: CD40 ligand (CD40L) deficiency, an X-linked primary immunodeficiency, causes recurrent sinopulmonary, Pneumocystis and Cryptosporidium species infections. Long-term survival with supportive therapy is poor. Currently, the only curative treatment is hematopoietic stem cell transplantation (HSCT).